DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactCompany

UPL Limited — Sale or disposal

NSE 2 hrs ago·29 Jul 2026, 3:03 pm

UPL

UPL Limited has informed the stock exchanges that it is selling its entire stake in its joint venture, Bioplanta Nutricao Vegetal. This move involves disposing of the company's shareholding in the Brazilian entity.

This divestment is a strategic shift for UPL. It signals the company's intent to streamline its global portfolio and focus on core business operations. For investors, this is a neutral-to-positive development as it often indicates a focus on efficiency and reducing complex cross-border structures.

Investors should monitor the finalization of the deal and the expected use of the proceeds. The impact on UPL's financials and its future growth strategy will be key factors to watch in the coming quarters.